171 related articles for article (PubMed ID: 27223469)
1. Multifunctional microbeads for drug delivery in TACE.
Bannerman D; Wan W
Expert Opin Drug Deliv; 2016 Sep; 13(9):1289-300. PubMed ID: 27223469
[TBL] [Abstract][Full Text] [Related]
2. [Economic impact of transarterial chemoembolization with drug eluting beads in the treatment of hepatocellular carcinoma].
Malbranche C; Boulin M; Guiu B; Pernot C; Cercueil JP; Serge Aho L; Musat A; Bedenne L; Hillon P; Guignard MH; Fagnoni P
Bull Cancer; 2011 Jun; 98(6):671-8. PubMed ID: 21642049
[TBL] [Abstract][Full Text] [Related]
3. Transarterial therapies for hepatocellular carcinoma.
Sangro B; D'Avola D; Iñarrairaegui M; Prieto J
Expert Opin Pharmacother; 2011 May; 12(7):1057-73. PubMed ID: 21470073
[TBL] [Abstract][Full Text] [Related]
4. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
5. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.
Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH
Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821
[TBL] [Abstract][Full Text] [Related]
6. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.
Facciorusso A
World J Gastroenterol; 2018 Jan; 24(2):161-169. PubMed ID: 29375202
[TBL] [Abstract][Full Text] [Related]
7. Bench-to-bedside development of multifunctional flexible embolic agents.
Wang D; Rao W
Theranostics; 2023; 13(7):2114-2139. PubMed ID: 37153738
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
Chen P; Yuan P; Chen B; Sun J; Shen H; Qian Y
Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):75-85. PubMed ID: 27350573
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery in transarterial chemoembolization of hepatocellular carcinoma: Ex vivo evaluation using transparent tissue imaging.
Hong S; Choi WS; Purushothaman B; Koh J; Kim HC; Chung JW; Song JM; Choi JW
Acta Biomater; 2022 Dec; 154():523-535. PubMed ID: 36374750
[TBL] [Abstract][Full Text] [Related]
10. Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma.
Jia G; Van Valkenburgh J; Chen AZ; Chen Q; Li J; Zuo C; Chen K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1749. PubMed ID: 34405552
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?
Biolato M; Marrone G; Racco S; Di Stasi C; Miele L; Gasbarrini G; Landolfi R; Grieco A
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):356-62. PubMed ID: 20496548
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma.
Yuan G; Liu Z; Wang W; Liu M; Xu Y; Hu W; Fan Y; Zhang X; Liu Y; Si G
J Nanobiotechnology; 2023 Feb; 21(1):68. PubMed ID: 36849981
[TBL] [Abstract][Full Text] [Related]
13. Smart nanoparticles and microbeads for interventional embolization therapy of liver cancer: state of the art.
Wu S; Fan K; Yang Q; Chen Z; Hou Y; Zou Y; Cai W; Kang L
J Nanobiotechnology; 2023 Feb; 21(1):42. PubMed ID: 36747202
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
15. Current concepts in transarterial chemoembolization of hepatocellular carcinoma.
Huppert P
Abdom Imaging; 2011 Dec; 36(6):677-83. PubMed ID: 21674193
[TBL] [Abstract][Full Text] [Related]
16. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.
Raoul JL; Sangro B; Forner A; Mazzaferro V; Piscaglia F; Bolondi L; Lencioni R
Cancer Treat Rev; 2011 May; 37(3):212-20. PubMed ID: 20724077
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Huang K; Zhou Q; Wang R; Cheng D; Ma Y
J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].
Ferrer Puchol MD; la Parra C; Esteban E; Vaño M; Forment M; Vera A; Cosín O
Radiologia; 2011; 53(3):246-53. PubMed ID: 21295802
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting embolic microspheres: State-of-the-art and emerging clinical applications.
Mikhail AS; Negussie AH; Mauda-Havakuk M; Owen JW; Pritchard WF; Lewis AL; Wood BJ
Expert Opin Drug Deliv; 2021 Mar; 18(3):383-398. PubMed ID: 33480306
[TBL] [Abstract][Full Text] [Related]
20. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
